Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

June 25, 2021

Study Completion Date

February 15, 2022

Conditions
Parotid NeoplasmThyroid NeoplasmsHead and Neck NeoplasmsSurgeryNerve InjuryImaging
Interventions
DRUG

Bevonescein

Bevonescein Sterile Solution is an intravenously administered, synthetic, peptide dye conjugate indicated for the real-time intraoperative fluorescence detection and localization of nerve tissue.

Trial Locations (3)

92037

University of California San Diego, San Diego

94305

Stanford University, Stanford

02114

Harvard-Mass Eye & Ear, Boston

Sponsors
All Listed Sponsors
lead

Alume Biosciences, Inc.

INDUSTRY

NCT04420689 - Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery | Biotech Hunter | Biotech Hunter